Raltegravir Added to Stable HAART in HIV-1 Infected Subjects With Viral Suppression and Low CD4 Recovery

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2010 by The Huesped Foundation.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by:
The Huesped Foundation
ClinicalTrials.gov Identifier:
NCT00562510
First received: November 21, 2007
Last updated: April 13, 2010
Last verified: April 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2010
  Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)